Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review.

Advances in Nutrition
Jikke T Boelens KeunOndine van de Rest

Abstract

Although levodopa remains the most effective drug for symptomatic management of Parkinson's Disease (PD), treatment during advanced disease stages may raise unpredictable motor fluctuations and other complications. Counteracting these complications with other pharmacological therapies may prompt a vicious circle of side effects, and here, nutritional therapy may have great potential. Knowledge about the role of diet in PD is emerging and multiple studies have investigated nutritional support specifically with respect to levodopa therapy. With this systematic review, we aim to give a comprehensive overview of dietary approaches to optimize levodopa treatment in PD. A systematic search was performed using the databases of PubMed and Scopus between January 1985 and September 2020. Nutritional interventions with the rationale to optimize levodopa therapy in human PD patients were eligible for this study and their quality was assessed with the Cochrane risk-of-bias tool. In total, we included 22 papers that addressed the effects of dietary proteins (n = 10), vitamins (n = 7), fiber (n = 2), soybeans (n = 1), caffeine (n = 1), and ketogenic diets (n = 1) on levodopa therapy. Interventions with protein redistribution diets (PRDs), die...Continue Reading

References

Oct 1, 1992·Clinical Neuropharmacology·R AstarloaJ G de Yébenes
Feb 1, 1992·Archives of Neurology·P J Karstaedt, J H Pincus
Jan 1, 1991·European Neurology·F BraccoL Battistin
Sep 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·J P FrankelG M Stern
Oct 1, 1987·Archives of Neurology·J L JuncosT N Chase
Oct 1, 1987·Archives of Neurology·J H Pincus, K M Barry
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·L V MetmanT N Chase
Mar 1, 1993·Neurology·P J Karstaedt, J H Pincus
May 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J G NuttW R Woodward
Oct 29, 2000·Trends in Neurosciences·J A ObesoJ G Nutt
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J E Ahlskog, M D Muenter
Mar 24, 2004·Parkinsonism & Related Disorders·Nicolas SimonFrançois Viallet
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo LambertiPaolo Livrea
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Padraig E O'SuilleabhainRamon Diaz-Arrastia
Dec 23, 2004·Clinical Neuropharmacology·Hiroshi NagayamaYasuo Katayama
Apr 5, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P LambertiP Livrea
May 24, 2005·Lancet Neurology·Anette Schrag
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Juan J GarciaMatilde Sierra
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nelida FernandezJuan J Garcia
Oct 4, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Markus HerrmannWolfgang Herrmann
May 23, 2006·Lancet Neurology·Lonneke M L de Lau, Monique M B Breteler
Jun 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Michela BarichellaGianni Pezzoli
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Fabrizio StocchiC Warren Olanow
Sep 20, 2008·Journal of Neurology·Guido AlvesJan Petter Larsen
Mar 19, 2009·Metabolic Brain Disease·Eliseu Felippe dos SantosMoacir Wajner
May 2, 2009·European Neurology·Robert A Hauser
May 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Thomas Müller, Wilfried Kuhn
Nov 26, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Seung Hun LeeSun Ju Chung
May 14, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Martin NevrlyPetr Hlustik
Jun 29, 2010·Annals of Neurology·Cory TothOksana Suchowersky
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Emanuele CeredaGianni Pezzoli
Nov 26, 2010·Journal of Neurology·Manuela Contin, Paolo Martinelli
Apr 13, 2011·Expert Opinion on Drug Metabolism & Toxicology·Thomas Müller
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yoland SmithMahlon R DeLong
Nov 2, 2011·Oman Medical Journal·Rabia BushraArshad Yar Khan
Nov 4, 2011·Neurology·Yusuf A Rajabally, Jean Martey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nursing Times
S Smith
Gaceta médica de México
J H Mateos
Handbook of Clinical Neurology
Thomas D Hälbig, W C Koller
Annals of Internal Medicine
M D Muenter
© 2021 Meta ULC. All rights reserved